Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Epigenomics AG
EPGNFCurrent price
0.79 USD
0 USD (0.00%)
Last closed
0.79 USD
Company
www.epigenomics.com
ISIN
unknown
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
PINK
Capitalization
691 368 USD
Yield for 12 month
-75.69 %
1Y
3Y
5Y
10Y
15Y
EPGNF
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. The company was founded in 1998 and is headquartered in Berlin, Germany. Address: Geneststrasse 5, Berlin, Germany, 10829
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.59 USDP/E ratio
–Dividend Yield
–Current Year
+339 227 USD
Last Year
+485 000 USD
Current Quarter
+68 114 USD
Last Quarter
+68 114 USD
Current Year
+282 315 USD
Last Year
+365 000 USD
Current Quarter
+61 158 USD
Last Quarter
+61 158 USD
Key Figures EPGNF
1 year
3 years
5 years
10 years
EBITDA
3 163 961 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
31.99 %
PEG Ratio
–
Return On Equity TTM
-175.41 %
Wall Street Target Price
8.59 USD
Revenue TTM
136 227 USD
Book Value
-9.53 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-44.3 %
Dividend Yield
–
Gross Profit TTM
6 067 000 USD
Earnings per share
-21.73 USD
Diluted Eps TTM
-21.73 USD
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
–
Profit Margin
2176.13 %
Dividend Analytics EPGNF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EPGNF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:5
Payout Ratio
–
Last Split Date
20.12.2023
Dividend Date
–
Stock Valuation EPGNF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.4487
Price Sales TTM
5.0751
Enterprise Value EBITDA
0.1315
Price Book MRQ
0.3257
Financials EPGNF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EPGNF
For 52 weeks
0.5 USD
2.5 USD
50 Day MA
0.79 USD
Shares Short Prior Month
–
200 Day MA
0.7 USD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart